Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bosentan in Progressive Pulmonary Sarcoidosis
2007-005117-18Phase 2Terminated
- Sponsor
- Medical University of Vienna
- Start
- Mar 2008
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Nucleic Acid-Directed Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised trial in pulmonary sarcoidosis comparing Bosentan add-on therapy with Placebo add-on therapy (2 arms). Primary endpoints: Composite clinical score for disease progression and Safety and tolerability of bosentan. Started Mar 2008; status: terminated.
02
Drugs
bosentan
03
Conditions
pulmonary sarcoidosis
Beyond the preview
Go deeper on 2007-005117-18.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2007-005117-18.